These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31196754)

  • 21. Differential anti-diabetic effects and mechanism of action of charantin-rich extract of Taiwanese Momordica charantia between type 1 and type 2 diabetic mice.
    Wang HY; Kan WC; Cheng TJ; Yu SH; Chang LH; Chuu JJ
    Food Chem Toxicol; 2014 Jul; 69():347-56. PubMed ID: 24751968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antioxidant properties and quantitative UPLC-MS analysis of phenolic compounds from extracts of fenugreek (Trigonella foenum-graecum) seeds and bitter melon (Momordica charantia) fruit.
    Kenny O; Smyth TJ; Hewage CM; Brunton NP
    Food Chem; 2013 Dec; 141(4):4295-302. PubMed ID: 23993618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In Vitro and In Vivo Screening of Wild Bitter Melon Leaf for Anti-Inflammatory Activity against
    Chuang LT; Shih YH; Huang WC; Lin LC; Hsu C; Chyuan JH; Tsai TH; Tsai PJ
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32961947
    [No Abstract]   [Full Text] [Related]  

  • 24. Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.
    Raina K; Kumar D; Agarwal R
    Semin Cancer Biol; 2016 Oct; 40-41():116-129. PubMed ID: 27452666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Debittering of bitter gourd juice using β-cyclodextrin: Mechanism and effect on antidiabetic potential.
    Deshaware S; Gupta S; Singhal RS; Joshi M; Variyar PS
    Food Chem; 2018 Oct; 262():78-85. PubMed ID: 29751925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review.
    Leung L; Birtwhistle R; Kotecha J; Hannah S; Cuthbertson S
    Br J Nutr; 2009 Dec; 102(12):1703-8. PubMed ID: 19825210
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Bortolotti M; Mercatelli D; Polito L
    Front Pharmacol; 2019; 10():486. PubMed ID: 31139079
    [No Abstract]   [Full Text] [Related]  

  • 28. Momordica charantia constituents and antidiabetic screening of the isolated major compounds.
    Harinantenaina L; Tanaka M; Takaoka S; Oda M; Mogami O; Uchida M; Asakawa Y
    Chem Pharm Bull (Tokyo); 2006 Jul; 54(7):1017-21. PubMed ID: 16819222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging Antitumor Activities of the Bitter Melon (Momordica charantia).
    Fang EF; Froetscher L; Scheibye-Knudsen M; Bohr VA; Wong JH; Ng TB
    Curr Protein Pept Sci; 2019; 20(3):296-301. PubMed ID: 29932035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bitter melon (Momordica charantia): a review of efficacy and safety.
    Basch E; Gabardi S; Ulbricht C
    Am J Health Syst Pharm; 2003 Feb; 60(4):356-9. PubMed ID: 12625217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies to improve palatability and increase consumption intentions for Momordica charantia (bitter melon): a vegetable commonly used for diabetes management.
    Snee LS; Nerurkar VR; Dooley DA; Efird JT; Shovic AC; Nerurkar PV
    Nutr J; 2011 Jul; 10():78. PubMed ID: 21794176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum sialic acid changes in non-insulin-dependant diabetes mellitus (NIDDM) patients following bitter melon (Momordica charantia) and rosiglitazone (Avandia) treatment.
    Inayat-ur-Rahman ; Malik SA; Bashir M; Khan R; Iqbal M
    Phytomedicine; 2009 May; 16(5):401-5. PubMed ID: 19362455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Momordica charantia for type 2 diabetes mellitus.
    Ooi CP; Yassin Z; Hamid TA
    Cochrane Database Syst Rev; 2012 Aug; (8):CD007845. PubMed ID: 22895968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effects of
    Richter E; Geetha T; Burnett D; Broderick TL; Babu JR
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro anti-diabetic activities and chemical analysis of polypeptide-k and oil isolated from seeds of Momordica charantia (bitter gourd).
    Ahmad Z; Zamhuri KF; Yaacob A; Siong CH; Selvarajah M; Ismail A; Nazrul Hakim M
    Molecules; 2012 Aug; 17(8):9631-40. PubMed ID: 22885359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of chemotypes in bitter melon by metabolomics: a plant with potential benefit for management of diabetes in traditional Chinese medicine.
    Zhou S; Allard PM; Wolfrum C; Ke C; Tang C; Ye Y; Wolfender JL
    Metabolomics; 2019 Jul; 15(8):104. PubMed ID: 31321563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients.
    Fuangchan A; Sonthisombat P; Seubnukarn T; Chanouan R; Chotchaisuwat P; Sirigulsatien V; Ingkaninan K; Plianbangchang P; Haines ST
    J Ethnopharmacol; 2011 Mar; 134(2):422-8. PubMed ID: 21211558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Momordica charantia and type 2 diabetes: from in vitro to human studies.
    Habicht SD; Ludwig C; Yang RY; Krawinkel MB
    Curr Diabetes Rev; 2014 Jan; 10(1):48-60. PubMed ID: 24295371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wild bitter melon (Momordica charantia Linn. var. abbreviata Ser.) extract and its bioactive components suppress Propionibacterium acnes-induced inflammation.
    Hsu C; Tsai TH; Li YY; Wu WH; Huang CJ; Tsai PJ
    Food Chem; 2012 Dec; 135(3):976-84. PubMed ID: 22953813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wild Bitter Melon Leaf Extract Inhibits Porphyromonas gingivalis-Induced Inflammation: Identification of Active Compounds through Bioassay-Guided Isolation.
    Tsai TH; Huang WC; Ying HT; Kuo YH; Shen CC; Lin YK; Tsai PJ
    Molecules; 2016 Apr; 21(4):454. PubMed ID: 27058519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.